Patient Home Monitoring (PHM) Announces Q1 Interactive Q&A Earnings Call Featuring Chairman Michael Dalsin and Director Roger Greene

SAN FRANCISCO, CALIFORNIA--(Marketwired - Feb. 4, 2014) - Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable company focused on rolling-up annuity-based healthcare service companies in the US and Canada, today announced that it will host an interactive 30 minutes Q&A earnings call to provide more in depth data and analysis about fiscal Q1 2014 results and plans going forward.

Participants for PHM will be Michael Dalsin (Chairman) and Roger Greene, (Director), both large individual shareholders and leaders of the M&A strategy for PHM.

The details of the call are:

February 6^th, 2014 at 4pm EST

US & Canada Toll Free - 800-768-5901

Financial professionals are invited to call in and ask questions. To pre-register as a qualified caller, please email ssteinkamp@myphm.com by 12 p.m. EST February 6^th, 2014.

About PHM

PHM is currently a positive cash flow and profitable company servicing patients with heart disease and other chronic health conditions, and will act as a platform for acquisitions. PHM is focused on a highly fragmented and developing market of small privately-held companies servicing chronically ill patients with multiple disease states caused mainly by age and obesity. Because of the new and highly fragmented nature of the market, PHM is actively working to identify and evaluate profitable, annuity-based companies to acquire their patient databases and technical expertise at favorable prices. PHM's post acquisition organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient. The expected result is growing EPS with each acquisition and growing revenue and profits from the cross selling efforts.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.